Logo image of CRWN.CA

CROWN CAPITAL PARTNERS INC (CRWN.CA) Stock Fundamental Analysis

Canada - TSX:CRWN - CA22821L1040 - Common Stock

0.63 CAD
-0.04 (-5.97%)
Last: 10/14/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CRWN. CRWN was compared to 81 industry peers in the Capital Markets industry. CRWN has a bad profitability rating. Also its financial health evaluation is rather negative. CRWN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CRWN had negative earnings in the past year.
CRWN had a positive operating cash flow in the past year.
In the past 5 years CRWN reported 4 times negative net income.
In the past 5 years CRWN always reported a positive cash flow from operatings.
CRWN.CA Yearly Net Income VS EBIT VS OCF VS FCFCRWN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

CRWN has a Return On Assets of -13.29%. This is amonst the worse of the industry: CRWN underperforms 85.19% of its industry peers.
Looking at the Return On Equity, with a value of -494.03%, CRWN is doing worse than 90.12% of the companies in the same industry.
Industry RankSector Rank
ROA -13.29%
ROE -494.03%
ROIC N/A
ROA(3y)-10.46%
ROA(5y)-6.81%
ROE(3y)-129.97%
ROE(5y)-80.67%
ROIC(3y)N/A
ROIC(5y)N/A
CRWN.CA Yearly ROA, ROE, ROICCRWN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

In the last couple of years the Operating Margin of CRWN has declined.
With a decent Gross Margin value of 41.61%, CRWN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
CRWN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CRWN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.61%
OM growth 3Y-54.1%
OM growth 5Y-48.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.85%
GM growth 5Y-14.71%
CRWN.CA Yearly Profit, Operating, Gross MarginsCRWN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

3

2. Health

2.1 Basic Checks

CRWN has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CRWN has less shares outstanding
The debt/assets ratio for CRWN is higher compared to a year ago.
CRWN.CA Yearly Shares OutstandingCRWN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CRWN.CA Yearly Total Debt VS Total AssetsCRWN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -0.24, we must say that CRWN is in the distress zone and has some risk of bankruptcy.
CRWN's Altman-Z score of -0.24 is on the low side compared to the rest of the industry. CRWN is outperformed by 82.72% of its industry peers.
CRWN has a debt to FCF ratio of 3.98. This is a good value and a sign of high solvency as CRWN would need 3.98 years to pay back of all of its debts.
CRWN has a better Debt to FCF ratio (3.98) than 67.90% of its industry peers.
CRWN has a Debt/Equity ratio of 10.21. This is a high value indicating a heavy dependency on external financing.
CRWN has a worse Debt to Equity ratio (10.21) than 91.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 10.21
Debt/FCF 3.98
Altman-Z -0.24
ROIC/WACCN/A
WACCN/A
CRWN.CA Yearly LT Debt VS Equity VS FCFCRWN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

CRWN has a Current Ratio of 0.70. This is a bad value and indicates that CRWN is not financially healthy enough and could expect problems in meeting its short term obligations.
CRWN has a Current ratio of 0.70. This is comparable to the rest of the industry: CRWN outperforms 48.15% of its industry peers.
CRWN has a Quick Ratio of 0.70. This is a bad value and indicates that CRWN is not financially healthy enough and could expect problems in meeting its short term obligations.
CRWN has a Quick ratio (0.66) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.66
CRWN.CA Yearly Current Assets VS Current LiabilitesCRWN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

3

3. Growth

3.1 Past

CRWN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.40%, which is quite impressive.
The Revenue has grown by 8.45% in the past year. This is quite good.
CRWN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.85% yearly.
EPS 1Y (TTM)27.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.17%
Revenue 1Y (TTM)8.45%
Revenue growth 3Y18.67%
Revenue growth 5Y14.85%
Sales Q2Q%6.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y630.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRWN.CA Yearly Revenue VS EstimatesCRWN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
CRWN.CA Yearly EPS VS EstimatesCRWN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 -1 -1.5 -2

6

4. Valuation

4.1 Price/Earnings Ratio

CRWN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CRWN is valuated cheaply with a Price/Forward Earnings ratio of 0.90.
100.00% of the companies in the same industry are more expensive than CRWN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CRWN to the average of the S&P500 Index (23.04), we can say CRWN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.9
CRWN.CA Price Earnings VS Forward Price EarningsCRWN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRWN is valued cheaply inside the industry as 93.83% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than CRWN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.23
EV/EBITDA 6.47
CRWN.CA Per share dataCRWN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

CRWN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CRWN!.
Industry RankSector Rank
Dividend Yield N/A

CROWN CAPITAL PARTNERS INC

TSX:CRWN (10/14/2025, 7:00:00 PM)

0.63

-0.04 (-5.97%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-10 2025-11-10
Inst Owners31.26%
Inst Owner ChangeN/A
Ins Owners28.11%
Ins Owner ChangeN/A
Market Cap3.77M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.9
P/S 0.05
P/FCF 0.23
P/OCF 0.15
P/B 0.98
P/tB 2.56
EV/EBITDA 6.47
EPS(TTM)-3.38
EYN/A
EPS(NY)0.7
Fwd EY111.71%
FCF(TTM)2.76
FCFY438.55%
OCF(TTM)4.12
OCFY653.93%
SpS12.74
BVpS0.64
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.29%
ROE -494.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.61%
FCFM 21.69%
ROA(3y)-10.46%
ROA(5y)-6.81%
ROE(3y)-129.97%
ROE(5y)-80.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-54.1%
OM growth 5Y-48.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.85%
GM growth 5Y-14.71%
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 10.21
Debt/FCF 3.98
Debt/EBITDA 3.95
Cap/Depr 63.42%
Cap/Sales 10.65%
Interest Coverage N/A
Cash Conversion 248.25%
Profit Quality N/A
Current Ratio 0.7
Quick Ratio 0.66
Altman-Z -0.24
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)43.75%
Cap/Depr(5y)42.25%
Cap/Sales(3y)6.83%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.17%
EPS Next Y630.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.45%
Revenue growth 3Y18.67%
Revenue growth 5Y14.85%
Sales Q2Q%6.31%
Revenue Next Year11.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-257.17%
EBIT growth 3Y-45.53%
EBIT growth 5Y-40.65%
EBIT Next Year957.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1060.58%
FCF growth 3Y38.54%
FCF growth 5Y25.25%
OCF growth 1Y1169.9%
OCF growth 3Y46.98%
OCF growth 5Y16.44%